1. Home
  2. KULR vs PVLA Comparison

KULR vs PVLA Comparison

Compare KULR & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KULR
  • PVLA
  • Stock Information
  • Founded
  • KULR 2013
  • PVLA 2015
  • Country
  • KULR United States
  • PVLA United States
  • Employees
  • KULR N/A
  • PVLA N/A
  • Industry
  • KULR Electrical Products
  • PVLA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KULR Technology
  • PVLA Health Care
  • Exchange
  • KULR Nasdaq
  • PVLA Nasdaq
  • Market Cap
  • KULR 275.2M
  • PVLA 308.2M
  • IPO Year
  • KULR N/A
  • PVLA N/A
  • Fundamental
  • Price
  • KULR $1.25
  • PVLA $23.59
  • Analyst Decision
  • KULR Strong Buy
  • PVLA Strong Buy
  • Analyst Count
  • KULR 2
  • PVLA 6
  • Target Price
  • KULR $5.00
  • PVLA $43.50
  • AVG Volume (30 Days)
  • KULR 13.1M
  • PVLA 93.0K
  • Earning Date
  • KULR 03-27-2025
  • PVLA 05-15-2025
  • Dividend Yield
  • KULR N/A
  • PVLA N/A
  • EPS Growth
  • KULR N/A
  • PVLA N/A
  • EPS
  • KULR N/A
  • PVLA N/A
  • Revenue
  • KULR $10,737,481.00
  • PVLA N/A
  • Revenue This Year
  • KULR $6.31
  • PVLA N/A
  • Revenue Next Year
  • KULR $76.78
  • PVLA N/A
  • P/E Ratio
  • KULR N/A
  • PVLA N/A
  • Revenue Growth
  • KULR 9.23
  • PVLA N/A
  • 52 Week Low
  • KULR $0.20
  • PVLA $6.20
  • 52 Week High
  • KULR $5.49
  • PVLA $29.27
  • Technical
  • Relative Strength Index (RSI)
  • KULR 38.62
  • PVLA N/A
  • Support Level
  • KULR $1.42
  • PVLA N/A
  • Resistance Level
  • KULR $1.85
  • PVLA N/A
  • Average True Range (ATR)
  • KULR 0.18
  • PVLA 0.00
  • MACD
  • KULR 0.00
  • PVLA 0.00
  • Stochastic Oscillator
  • KULR 5.47
  • PVLA 0.00

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.

Share on Social Networks: